UK markets open in 5 hours 24 minutes

Biocartis Group NV (BCARTB.XC)

Cboe UK - Cboe UK Real-time price. Currency in EUR
Add to watchlist
0.60850.0000 (0.00%)
At close: 03:30PM BST
Show:
Income statement
Balance sheet
Annual

Cash flow

All numbers in thousands
Breakdown
ttm
31/12/2022
31/12/2021
31/12/2020
31/12/2019
Cash flows from operating activities
Net income
-67,868
-65,381
-71,472
-62,934
-64,068
Depreciation & amortisation
10,383
10,481
9,845
9,748
9,719
Stock-based compensation
510
640
760
1,432
1,225
Change in working capital
-11,581
-3,857
-9,648
3,325
-4,493
Inventory
-826
-5,297
-2,737
-4,042
-3,858
Other working capital
-51,440
-46,792
-69,471
-42,287
-56,769
Other non-cash items
23,930
17,612
8,249
15,688
7,971
Net cash provided by operating activities
-49,963
-44,855
-65,716
-39,267
-54,254
Cash flows from investing activities
Investments in property, plant and equipment
-1,477
-1,937
-3,755
-3,020
-2,515
Acquisitions, net
-
-1,000
0
-1,000
-2,989
Purchases of investments
-
-2,500
-
-
-
Net cash used for investing activities
-4,969
-5,431
-3,748
-4,007
-5,496
Net change in cash
6,753
-27,823
-70,668
-54,797
115,273
Cash at beginning of period
19,724
53,522
123,668
178,725
63,539
Cash at end of period
26,477
26,125
53,522
123,668
178,725
Free cash flow
Operating cash flow
-49,963
-44,855
-65,716
-39,267
-54,254
Capital expenditure
-1,477
-1,937
-3,755
-3,020
-2,515
Free cash flow
-51,440
-46,792
-69,471
-42,287
-56,769